The Multicellular Origin of Cancer and the Evolution of Oncogenesis: Part 9

PART 9 (Final Part): Discussion & References

Discussion

In oncogenesis, where an unreserved display of Darwin’s Evolution Theory is seen [1], what all we are able to see so far is only a tiny fraction of its happenings and changes reflected to the cancer cell’s morphology. And therefore, what all we know today in this scarce provision of the cell’s abundant resources and data in a partial display of its rich composition and orchestration, and in its external relations, is quite limited, mostly because our comprehension of it is limited. Our confinement within this limitation, also in other certain fields of clinical and research medicine, render our interpretation of it linearly insufficient, and it often puts us in efficacy and hindrance which we most frustratedly experience in today’s Oncology where unavailing scientific beliefs and views archaically continue to feed analytical preoccupations. Whence there is a fundamental reason for us to open wider paths and avenues to “understanding and solving oncogenesis” with rational approaches and cataclysmic insights, and to embrace overall management of the oncologic disease with radical implements. In this regard, we must aim at opening a new, reformative, reconstituting era of oncology not only in the fundamentals and basics of universal cancer research and studies, but also in the practice and management of Oncology at clinical and molecular levels where new, better thought of and more effective strategies of oncotherapy are crucially needed.

References

1. Darwin CR.  On the Origin of Species by Means of Natural Selection, or the Preservation of Favoured Races in the Struggle for Life. John Murray 1859,  London.
2. Merlo LM, Pepper JW, Reid BJ, Maley CC.  Cancer as an evolutionary and ecological process. Nat Rev Cancer 2006;  6:924–935.3
3. Pepper J, Findlay CS, Kassen R, Spencer S, Maley C.  Cancer research meets evolutionary biology. Evolutionary Applications 2009; 2:62–70.
4. Graves M, Maley CC. Clonal evolution in cancer. Nature 2012; 481:306-313.
5. Campbell PJ, Yachida S,  Mudie LJ et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer.Nature 2010; 467:1109–1113.
6. Yachida S, Jones S, Bozic I et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer.Nature2010; 467:1114–1117.
7. Klein G. Toward a genetics of cancer resistance. PNAS 2009; 106:859-863.
8. Podlaha O, Riester M, De S, Michor F. Evolution of the cancer genome. Trends in Genetics 2012; 28(4):155-163.
9. Malaise EP, Chavaudra N, Tubiana M. The relationship between growth rate,  labelling index and histological type of human solid tumours. Eur J Cancer 1973; 9(4):305-12.
10. Luzzi KJ, MacDonald IC, Schmidt EE, Groom AC.  Multistep Nature of Metastatic Inefficiency. Am J Pathol 1998; 153(3):865–873